Another mechanism proposed by our hypothesis is that the chronic inflammatory state in DM patients might aggravate insulin resistance via inflammatory mediators such as interleukin-6 (IL-6) and nuclear factor kappa B (NF-kB). This evidence concerns the gene NFKB1 and diabetes mellitus.